Phunware (PHUN) Competitors $3.05 0.00 (-0.03%) As of 09:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PHUN vs. MXCT, III, PMTS, LTBR, AHG, TSSI, PHLT, TCX, RGP, and OABIShould you be buying Phunware stock or one of its competitors? The main competitors of Phunware include MaxCyte (MXCT), Information Services Group (III), CPI Card Group (PMTS), Lightbridge (LTBR), Akso Health Group (AHG), TSS (TSSI), Performant Healthcare, Inc. - Common Stock (PHLT), Tucows (TCX), Resources Connection (RGP), and OmniAb (OABI). These companies are all part of the "business services" industry. Phunware vs. MaxCyte Information Services Group CPI Card Group Lightbridge Akso Health Group TSS Performant Healthcare, Inc. - Common Stock Tucows Resources Connection OmniAb Phunware (NASDAQ:PHUN) and MaxCyte (NASDAQ:MXCT) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking. Do institutionals & insiders have more ownership in PHUN or MXCT? 7.6% of Phunware shares are owned by institutional investors. Comparatively, 68.8% of MaxCyte shares are owned by institutional investors. 1.2% of Phunware shares are owned by company insiders. Comparatively, 3.0% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in PHUN or MXCT? Phunware received 63 more outperform votes than MaxCyte when rated by MarketBeat users. However, 80.00% of users gave MaxCyte an outperform vote while only 65.22% of users gave Phunware an outperform vote. CompanyUnderperformOutperformPhunwareOutperform Votes7565.22% Underperform Votes4034.78% MaxCyteOutperform Votes1280.00% Underperform Votes320.00% Which has better earnings and valuation, PHUN or MXCT? MaxCyte has higher revenue and earnings than Phunware. MaxCyte is trading at a lower price-to-earnings ratio than Phunware, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhunware$2.96M20.81-$52.78M-$0.81-3.76MaxCyte$37.68M6.25-$37.92M-$0.40-5.54 Does the media prefer PHUN or MXCT? In the previous week, Phunware had 12 more articles in the media than MaxCyte. MarketBeat recorded 12 mentions for Phunware and 0 mentions for MaxCyte. MaxCyte's average media sentiment score of 0.18 beat Phunware's score of -0.32 indicating that MaxCyte is being referred to more favorably in the news media. Company Overall Sentiment Phunware Neutral MaxCyte Neutral Which has more risk and volatility, PHUN or MXCT? Phunware has a beta of 2.58, indicating that its share price is 158% more volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Is PHUN or MXCT more profitable? MaxCyte has a net margin of -78.36% compared to Phunware's net margin of -867.61%. MaxCyte's return on equity of -16.00% beat Phunware's return on equity.Company Net Margins Return on Equity Return on Assets Phunware-867.61% -244.22% -119.14% MaxCyte -78.36%-16.00%-13.93% Do analysts recommend PHUN or MXCT? Phunware presently has a consensus target price of $6.50, suggesting a potential upside of 113.18%. MaxCyte has a consensus target price of $7.50, suggesting a potential upside of 238.75%. Given MaxCyte's stronger consensus rating and higher probable upside, analysts clearly believe MaxCyte is more favorable than Phunware.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phunware 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50MaxCyte 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryMaxCyte beats Phunware on 13 of the 18 factors compared between the two stocks. Get Phunware News Delivered to You Automatically Sign up to receive the latest news and ratings for PHUN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PHUN vs. The Competition Export to ExcelMetricPhunwareData processing & preparation IndustryComputer SectorNASDAQ ExchangeMarket Cap$61.93M$4.31B$25.24B$8.48BDividend YieldN/A3.85%2.89%4.11%P/E Ratio-3.7686.1645.0320.05Price / Sales20.811,266.122,137.27116.44Price / CashN/A33.7434.7834.62Price / Book-1.496.456.784.61Net Income-$52.78M$44.05M$737.99M$248.19M7 Day Performance-1.96%-0.23%0.51%2.56%1 Month Performance20.99%28.99%16.25%16.18%1 Year Performance-55.62%19.61%52,512.16%8.16% Phunware Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PHUNPhunware1.0537 of 5 stars$3.050.0%$6.50+113.2%-53.9%$61.93M$2.96M-3.76120MXCTMaxCyte2.4917 of 5 stars$2.27-3.8%$7.50+230.4%-54.1%$241.34M$38.63M-6.6880IIIInformation Services Group2.9224 of 5 stars$4.80+3.4%$5.50+14.6%+53.7%$231.62M$247.59M-68.561,340High Trading VolumePMTSCPI Card Group4.2648 of 5 stars$20.48-4.8%$36.75+79.4%-19.5%$231.04M$480.60M15.631,150High Trading VolumeLTBRLightbridge0.5039 of 5 stars$10.93+14.7%N/A+208.5%$228.27MN/A-14.576Gap UpAHGAkso Health GroupN/A$1.53+8.3%N/A+117.7%$222.23M$8.45M0.0040Gap DownTSSITSSN/A$8.23+12.3%N/A+690.5%$205.92M$148.14M45.7270Earnings ReportPHLTPerformant Healthcare, Inc. - Common StockN/A$2.58+3.6%N/AN/A$202.04M$122.98M-25.80930News CoveragePositive NewsGap UpHigh Trading VolumeTCXTucows0.4682 of 5 stars$17.24+1.4%N/A+1.2%$190.35M$362.28M-1.681,000RGPResources Connection3.3747 of 5 stars$5.70+4.6%$10.00+75.4%-53.8%$188.49M$560.19M-3.064,260Positive NewsGap UpOABIOmniAb3.2628 of 5 stars$1.43-0.7%$7.00+389.5%-64.9%$174.65M$26.74M-2.317 Related Companies and Tools Related Companies MaxCyte Competitors Information Services Group Competitors CPI Card Group Competitors Lightbridge Competitors Akso Health Group Competitors TSS Competitors Performant Healthcare, Inc. - Common Stock Competitors Tucows Competitors Resources Connection Competitors OmniAb Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PHUN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phunware, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phunware With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
